| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.18 | 0.004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |